.

New High-Tech Startup at LIHTI Nets $12M in Funding

Coferon Inc. gets venture capital funds.

A new biotechnology company based at Stony Brook's is the recipient of $12 million in venture capital funding, according to a report published Wednesday in Newsday.

Coferon Inc. is led by CEO Colin Goddard and chief scientist Lee Arnold, both formerly of OSI Pharmaceuticals, which was sold to a Japanese company in 2010 for $4 billion. The company's mission is to expand technology used to make more potent drugs to fight cancer and other diseases.

"If it is successful in its greatest potential, this could be a whole new class of drugs," Goddard told Newsday.

Click here to read the full story from Newsday (subscription required).

Boards

More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »